Ashfield Pharmacovigilance is pleased to announce the addition of Annette Lamp, M.D. to the role of Senior Medical Director.
Dr. Lamp will play a critical role in leading and developing Ashfield’s Medical Directors and Drug Safety Scientists, as well as ensuring that Ashfield remains at the forefront of pharmacovigilance practices and methodologies.
Prior to joining Ashfield Pharmacovigilance, Dr. Lamp served as the Medical Director of Global Safety at Amgen. Dr. Lamp’s background spans across immunology, oncology, hematology and nephrology in clinical development and clinical research – working in both a pre and post marketing environment. In addition to being a MD, Dr. Lamp’s credentials include RN and PA-C. She has practiced in clinics and hospital settings such as MD Anderson Cancer Center in Houston Texas where she worked as a medical provider and sub-investigator.
Dr. Lamp has a distinguished career in the pharma industry in roles of increasing responsibilities, including positions with Oncogenex, UCB Pharma, OSI Pharmaceutical and Pharmacia.
Michael Pierce, Chief Compliance and Risk Management Officer of Ashfield Pharmacovigilance, says, “We are pleased to announce the addition of Annette Lamp. Dr. Lamp brings a wealth of global safety and pharmacovigilance experience that will benefit our growing number of clients.”
Outside of Ashfield Dr. Lamp enjoys travelling with her husband and practices hot yoga.